S Lee, H Kaneko, I Sekigawa, Y Tokano, Y Takasaki, H Hashimoto
{"title":"Circulating interleukin-16 in systemic lupus erythematosus.","authors":"S Lee, H Kaneko, I Sekigawa, Y Tokano, Y Takasaki, H Hashimoto","doi":"10.1093/rheumatology/37.12.1334","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the relationship between interleukin (IL)-16 and systemic lupus erythematosus (SLE).</p><p><strong>Methods: </strong>Serum levels of IL-16 were examined in SLE patients using an enzyme-linked immunosorbent assay (ELISA).</p><p><strong>Results: </strong>The serum level of IL-16 in the patients was much higher than that in healthy volunteers (P < 0.001). An increase in IL-16 was observed in proportion to the activity of SLE assessed by the SLE Disease Activity Index (SLEDAI) score (P < 0.0001).</p><p><strong>Conclusions: </strong>Our observations suggest an interaction between disease activity and the production of IL-16 in SLE, and reveal that IL-16 is a useful indicator of disease activity. This is the first report describing the relationship between IL-16 and SLE.</p>","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1334-7"},"PeriodicalIF":0.0000,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1334","citationCount":"80","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rheumatology/37.12.1334","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 80
Abstract
Objective: To investigate the relationship between interleukin (IL)-16 and systemic lupus erythematosus (SLE).
Methods: Serum levels of IL-16 were examined in SLE patients using an enzyme-linked immunosorbent assay (ELISA).
Results: The serum level of IL-16 in the patients was much higher than that in healthy volunteers (P < 0.001). An increase in IL-16 was observed in proportion to the activity of SLE assessed by the SLE Disease Activity Index (SLEDAI) score (P < 0.0001).
Conclusions: Our observations suggest an interaction between disease activity and the production of IL-16 in SLE, and reveal that IL-16 is a useful indicator of disease activity. This is the first report describing the relationship between IL-16 and SLE.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
